BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35976671)

  • 1. Spindle Cell Lesions of the Breast: A Diagnostic Algorithm.
    Ni Y; Tse GM
    Arch Pathol Lab Med; 2023 Jan; 147(1):30-37. PubMed ID: 35976671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spindle cell lesions of the breast--the pathologic differential diagnosis.
    Tse GM; Tan PH; Lui PC; Putti TC
    Breast Cancer Res Treat; 2008 May; 109(2):199-207. PubMed ID: 17636400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign and malignant spindle cell lesions of the breast.
    Brogi E
    Semin Diagn Pathol; 2004 Feb; 21(1):57-64. PubMed ID: 15074560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of enhancer of zeste homolog 2 (EZH2) expression in spindle cell lesions of the breast.
    Genco IS; Hackman K; Morrar D; Jin C; Santagada E; Hajiyeva S
    Pathol Int; 2021 Jun; 71(6):415-419. PubMed ID: 33730427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-needle aspiration cytology of spindle cell lesions of the breast.
    Chhieng DC; Cangiarella JF; Waisman J; Fernandez G; Cohen JM
    Cancer; 1999 Dec; 87(6):359-71. PubMed ID: 10603190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle cell lesions of the breast: a diagnostic approach.
    Rakha EA; Brogi E; Castellano I; Quinn C
    Virchows Arch; 2022 Jan; 480(1):127-145. PubMed ID: 34322734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to the diagnosis of spindle cell lesions of the breast.
    Rakha EA; Aleskandarany MA; Lee AH; Ellis IO
    Histopathology; 2016 Jan; 68(1):33-44. PubMed ID: 26768028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast.
    Lee AH
    Histopathology; 2008 Jan; 52(1):45-57. PubMed ID: 18171416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics.
    Cloutier JM; Moreland A; Wang L; Kunder CA; Allard G; Wang A; Krings G; Charville GW; Bean GR
    Hum Pathol; 2023 Sep; 139():17-26. PubMed ID: 37392946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spindle cell tumours of the breast: practical approach to diagnosis.
    Al-Nafussi A
    Histopathology; 1999 Jul; 35(1):1-13. PubMed ID: 10383708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Diagnosis of Benign Spindle Cell Lesions.
    Magro G
    Surg Pathol Clin; 2018 Mar; 11(1):91-121. PubMed ID: 29413661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low to Intermediate (Borderline) Grade Breast Spindle Cell Lesions on Needle Biopsy: Diagnostic Approach and Clinical Management.
    Russell DH; Montgomery EA; Susnik B
    Adv Anat Pathol; 2022 Sep; 29(5):309-323. PubMed ID: 35838633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
    Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
    Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
    Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
    J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic lesions of the breast.
    Lerwill MF
    Semin Diagn Pathol; 2004 Feb; 21(1):48-56. PubMed ID: 15074559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phyllodes tumours of the breast: a consensus review.
    Tan BY; Acs G; Apple SK; Badve S; Bleiweiss IJ; Brogi E; Calvo JP; Dabbs DJ; Ellis IO; Eusebi V; Farshid G; Fox SB; Ichihara S; Lakhani SR; Rakha EA; Reis-Filho JS; Richardson AL; Sahin A; Schmitt FC; Schnitt SJ; Siziopikou KP; Soares FA; Tse GM; Vincent-Salomon A; Tan PH
    Histopathology; 2016 Jan; 68(1):5-21. PubMed ID: 26768026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical approach to diagnosis of bland-looking spindle cell lesions of the breast.
    Magro G; Salvatorelli L; Puzzo L; Piombino E; Bartoloni G; Broggi G; Vecchio GM
    Pathologica; 2019 Dec; 111(4):344-360. PubMed ID: 31965112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA binding protein 3 (GATA3) as a marker for metaplastic spindle cell carcinoma of the breast.
    Jin C; Hacking S; Sajjan S; Kamanda S; Bhuiya T; Nasim M
    Pathol Res Pract; 2021 May; 221():153413. PubMed ID: 33770555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myofibroblastic, fibroblastic and myoid lesions of the breast.
    Krings G; McIntire P; Shin SJ
    Semin Diagn Pathol; 2017 Sep; 34(5):427-437. PubMed ID: 28751104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.